Resistance	Microbe	Outcome
Amoxicillin And Beta-Lactamase Inhibitor /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 11.00 18 No use 0.00 14
Ampicillin /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 84.00 18 No use 93.00 14
Cefoxitin /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 5.00 18 No use 0.00 14
Chloramphenicol /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 26.00 18 No use 43.00 14
Ciprofloxacin /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 0.00 18 No use 0.00 14
Gentamicin /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 11.00 18 No use 7.00 14
Nalidixic Acid /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 5.00 18 No use 7.00 14
Streptomycin /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 74.00 18 No use 93.00 14
Sulfonamides, Combinations With Other Antibacterials Excl. Trimethoprim /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 68.00 18 No use 71.00 14
Tetracycline /	Escherichia None	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 100.00 18 No use 100.00 14
Sulfamethoxazole And Trimethoprim /	Escherichia coli	See: Figure 2 AMR+ (%) AMR- (%) Total (n) Flavophospholipol use 5.00 18 No use 57.00 14